Teva Pharmaceutical Industries Limited revenue by segment TEVA

Annual Quarterly

Teva Pharmaceutical Industries Limited splits its revenue into 5 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was United States at $9.2 billion, 53% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2013 Dec 31, 2013	FY 2012 Dec 31, 2012
Revenue	17,230	17,258	16,544	15,846	14,925	15,878	16,659	16,887	18,271	20,314	20,317
United States	—	9,186 +14.3% share 53.2%	8,034 +3.9% share 48.6%	7,731 +10.4% share 48.8%	7,003 share 46.9%	—	—	—	—	—	—
North America	—	—	—	8,124 +9.0% share 51.3%	7,452 -4.6% share 49.9%	7,809 -7.6% share 49.2%	8,447 -1.1% share 50.7%	8,542 -8.1% share 50.6%	9,297 share 50.9%	—	—
Europe	—	5,040 -1.2% share 29.2%	5,103 +5.5% share 30.8%	4,837 +6.9% share 30.5%	4,525 -7.4% share 30.3%	4,886 +2.7% share 30.8%	4,757 -0.8% share 28.6%	4,795 -7.5% share 28.4%	5,186 share 28.4%	—	—
International Markets	—	2,162 -12.2% share 12.5%	2,463 +4.8% share 14.9%	2,351 +23.5% share 14.8%	1,903 -6.3% share 12.8%	2,032 -5.7% share 12.8%	2,154 -4.1% share 12.9%	2,246 -7.3% share 13.3%	2,422 share 13.3%	—	—
Other Activities	—	870 -7.8% share 5.0%	944 +1.9% share 5.7%	926 -11.4% share 5.8%	1,045 -9.2% share 7.0%	1,151 -11.6% share 7.2%	1,302 -0.2% share 7.8%	1,304 -4.5% share 7.7%	1,366 share 7.5%	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: TEVA (NYSE)
Fiscal year ends: December 31
Incorporated in: Israel
Headquarters: Tel Aviv
SEC filer status: Large accelerated filer
SEC CIK: 818686
Former names: TEVA PHARMACEUTICAL INDUSTRIES LIMITED (until Jan 16, 2001)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.